Immunohistochemistry PDL1 22C3 Test sale cost 3280 AED
FISH-NTRK 12 and 3 Gene Panel Test sale cost 3510 AED FISH-NTRK 12 and 3 Gene Panel Test Cost 3,900 د.إ Original price was: 3,900 د.إ.3,510 د.إCurrent price is: 3,510 د.إ.
LPL Expert Panel 2 Test sale cost 3280 AED LPL Expert Panel 2 Test Cost 3,640 د.إ Original price was: 3,640 د.إ.3,280 د.إCurrent price is: 3,280 د.إ.
Sale!

Immunohistochemistry PDL1 22C3 Test Cost

Original price was: 3,640 د.إ.Current price is: 3,280 د.إ.

-10%

The Immunohistochemistry PDL1 22C3 test is a diagnostic procedure utilized to identify the expression of the Programmed Death-Ligand 1 (PD-L1) protein in cancer cells. This test is particularly significant in the context of certain cancers, such as non-small cell lung cancer, as it helps in determining the suitability of patients for immunotherapy treatments targeting the PD-1/PD-L1 pathway. The 22C3 clone is used as a specific monoclonal antibody in this immunohistochemistry assay to detect PD-L1 expression.

Conducted at DNA Labs UAE, a reputable facility known for its advanced diagnostic solutions, the cost of the Immunohistochemistry PDL1 22C3 test is 3280 AED. This investment in testing is crucial for tailoring the most effective treatment plans for patients, potentially leading to better outcomes by utilizing therapies that specifically target the molecular profile of their cancer.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

IMMUNOHISTOCHEMISTRY PDL1 22C3 Test

Test Cost: 3280.0 AED

Test Name: IMMUNOHISTOCHEMISTRY PDL1 22C3 Test

Components: IMMUNOHISTOCHEMISTRY

Price: 3280.0 AED

Sample Condition: Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Site of biopsy and Clinical history.

Report Delivery: Sample Daily by 6 pm; Report Block: 5 daysTissue Biopsy: 5 days Tissue large complex: 7 days

Method: Immunohistochemistry

Test type: Cancer

Doctor: Oncologist

Test Department: HISTOLOGY

Pre Test Information: Provide a copy of the Histopathology report, Site of biopsy and Clinical history.

Test Details

The PD-L1 22C3 test is an immunohistochemistry (IHC) test used to assess the expression of programmed death-ligand 1 (PD-L1) in tumor tissues. PD-L1 is a protein that is expressed on the surface of cancer cells and interacts with the programmed cell death protein 1 (PD-1) receptor on immune cells, suppressing the immune response against the tumor. The PD-L1 22C3 test involves staining tumor tissue samples with a specific antibody that recognizes PD-L1. The antibody is labeled with a chromogen or fluorescent dye, which allows visualization of PD-L1 expression under a microscope. The stained tissue sections are then examined by a pathologist to determine the percentage of tumor cells expressing PD-L1 and the intensity of staining.

The PD-L1 22C3 test is commonly used to guide treatment decisions in certain types of cancer, particularly in patients who may benefit from immune checkpoint inhibitors, such as pembrolizumab. PD-1 inhibitors block the interaction between PD-L1 and PD-1, thus enhancing the immune response against the tumor. The results of the PD-L1 22C3 test can help oncologists determine the likelihood of response to PD-1 inhibitors and may be used to select patients who are more likely to benefit from this type of immunotherapy. However, it is important to note that PD-L1 expression is not the only factor influencing response to PD-1 inhibitors, and other biomarkers and clinical factors are also considered in treatment decisions.

Test Name IMMUNOHISTOCHEMISTRY PDL1 22C3 Test
Components IMMUNOHISTOCHEMISTRY
Price 3280.0 AED
Sample Condition Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Site of biopsy and Clinical history.
Report Delivery Sample Daily by 6 pm; Report Block: 5 daysTissue Biopsy: 5 days Tissue large complex : 7 days
Method Immunohistochemistry
Test type Cancer
Doctor Oncologist
Test Department: HISTOLOGY
Pre Test Information Provide a copy of the Histopathology report, Site of biopsy and Clinical history.
Test Details

The PD-L1 22C3 test is an immunohistochemistry (IHC) test used to assess the expression of programmed death-ligand 1 (PD-L1) in tumor tissues. PD-L1 is a protein that is expressed on the surface of cancer cells and interacts with the programmed cell death protein 1 (PD-1) receptor on immune cells, suppressing the immune response against the tumor.

The PD-L1 22C3 test involves staining tumor tissue samples with a specific antibody that recognizes PD-L1. The antibody is labeled with a chromogen or fluorescent dye, which allows visualization of PD-L1 expression under a microscope. The stained tissue sections are then examined by a pathologist to determine the percentage of tumor cells expressing PD-L1 and the intensity of staining.

The PD-L1 22C3 test is commonly used to guide treatment decisions in certain types of cancer, particularly in patients who may benefit from immune checkpoint inhibitors, such as pembrolizumab. PD-1 inhibitors block the interaction between PD-L1 and PD-1, thus enhancing the immune response against the tumor.

The results of the PD-L1 22C3 test can help oncologists determine the likelihood of response to PD-1 inhibitors and may be used to select patients who are more likely to benefit from this type of immunotherapy. However, it is important to note that PD-L1 expression is not the only factor influencing response to PD-1 inhibitors, and other biomarkers and clinical factors are also considered in treatment decisions.

SKU: TEST-4744 Category:

Related products